Problem drinking linked to increased risk of suicide and self-harm Problematic alcohol use is associated with increased odds of suicide or self-harm, according to a new study led by UCL researchers. Nov 2, 2022 0 33
Researchers find evidence for 'substantial' monkeypox transmission before symptoms appear A UK study published by The BMJ today has found evidence for "substantial" monkeypox transmission before symptoms appear or are detected (known as pre-symptomatic transmission). Nov 2, 2022 0 28
New insights into how exercise protects against neurodegenerative diseases Accumulating evidence finds that exercise can improve brain function and delay or prevent the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. While the underlying mechanisms remain unclear, ... Nov 2, 2022 0 11
Druggable targets found for treating rare, deadly nerve cancer MPNST Very few people, other than professionals and those close to the young people who have this rare form of cancer have ever heard of a malignant peripheral nerve sheath tumor (MPNST). Nov 2, 2022 0 27
Vitamin C may hold the key to improve efficacy of dendritic cell-derived anticancer cell therapies Researchers from the Epigenetics and Immune Disease Lab at the Josep Carreras Leukaemia Research Institute have recently shown that vitamin C improves the immunogenic properties of dendritic cells in vitro. Nov 2, 2022 0 5
Pinpointing the prevalence of mismatch repair (MMR)-deficient rectal adenocarcinomas A widely-circulated clinical trial published earlier this year in the New England Journal of Medicine (NEJM) described a new treatment that eradicated cancer in all 12 of its patients with locally advanced mismatch repair ... Nov 2, 2022 0 2
Dapagliflozin is not only clinically effective, but also cost-effective in patients with chronic kidney disease The burden of chronic kidney disease (CKD) to both health care systems and patients is considerable. Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, has been shown to be an efficacious treatment for CKD in the ... Nov 2, 2022 0 2
Largest trial to date shows that COMP360 psilocybin reduces depression symptoms A multicenter clinical trial led by COMPASS Pathways across 22 international sites, including the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and South London and Maudsley NHS Foundation ... Nov 2, 2022 1 91
Obesity drug helps teens lose weight, study finds A drug called semaglutide, which is approved for adults with obesity or overweight, also helps adolescents shed pounds and have healthier hearts, according to a new study published today in the New England Journal of Medicine ... Nov 2, 2022 0 79
Editorial: Finding the solution to obesity In the 20 years since Barbara Corkey, Ph.D., was named Editor in Chief of the journal Obesity, obesity among adults has risen significantly. Data from the National Center for Health Statistics show that one third of U.S. ... Nov 2, 2022 0 10
